Align Know-how’s board of administrators has licensed a brand new inventory repurchase program price US$1 billion, following the completion of its earlier US$1-billion buyback on Could 1.
The brand new program permits Align to repurchase as much as US$1 billion of its widespread inventory over the following three years. The prior authorization, accredited in January 2023, was accomplished on Could 1, 2025, with settlement on Could 2.
The announcement follows the discharge of Align’s first-quarter 2025 monetary outcomes on April 30, which confirmed a slight decline in complete income however beat earnings expectations. In April, Morgan Stanley additionally decreased Align’s worth goal from US$272 to US$249 however maintained its “obese” ranking, indicating continued confidence within the firm’s potential.
“The brand new US$1-billion program displays the power of our stability sheet and money circulation era.” John Morici, Align’s CFO and govt vice-president, international finance.
“The brand new US$1-billion program displays the power of our stability sheet and money circulation era, in addition to administration’s and our board’s continued confidence in our potential to capitalize on giant market alternatives in our goal markets and trajectory for progress,” stated John Morici, Align’s CFO and govt vice-president, international finance. “Returning capital to our shareholders via inventory repurchase packages, whereas concurrently investing in our strategic progress drivers, is per our capital allocation technique and dedication to rising shareholder worth.”
As of March 31, Align had roughly 73.1 million shares excellent and US$873 million in money and money equivalents.
Additionally learn: Dental shares downgraded? Right here is every little thing it is advisable know as a dentist
Additionally learn: Stats Canada: Dental sector surpasses pre-pandemic productiveness ranges by $851 million as job progress rebounds
Q1 report
In late April, the corporate reported Q1 revenues of US$979.3 million, marking a 1.8 per cent lower year-over-year. Nevertheless, Clear Aligner quantity elevated by 6.2 per cent to 642,300 instances, with remedies for teenagers and rising sufferers rising 13.3 per cent to 225,800 instances, pushed by continued adoption of Invisalign First.
Regardless of headwinds from unfavourable overseas alternate, Align reported a non-GAAP diluted earnings per share of US$2.13 in Q1 2025, surpassing the US$2.00 analysts’ forecast and demonstrating operational resilience.
For the second quarter, Align expects worldwide revenues to vary from US$1.05 billion to US$1.07 billion, up from Q1.
“We have now assessed the potential impression of China’s retaliatory tariffs and consider that we’re in a position to mitigate many of the tariff.” Align’s assertion.
Tariff outlook stays unsure
Align additionally addressed potential tariff impacts in its earnings launch. The corporate stated it expects an “incremental tariff, if carried out, to be utilized to switch costs on items shipped from Mexico.”
“As famous in President Trump’s govt order dated April 2, 2025, USMCA-compliant items are exempt from the tariffs beneath the order. Nevertheless, the U.S.-Mexico tariff scenario stays fluid, and we’re unable to foretell whether or not USMCA-compliant merchandise will stay exempt, whether or not there can be different modifications to the introduced order, or if further tariffs can be imposed sooner or later,” the corporate stated.
Align added it doesn’t anticipate vital tariff impacts on its operations in China, the place Clear Aligners are made for the Asian market.
“We have now assessed the potential impression of China’s retaliatory tariffs and consider that we’re in a position to mitigate many of the tariff publicity via changes in our provide chain,” it stated.
